Lupin Ltd Share Price – NSE /  BSE

Pharmaceuticals, Mid Cap

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg. Rivaroxaban Tablets are bioequivalent to Xarelto? Tablets, 10 mg, 15 mg, and 20 mg, of Janssen Pharmaceuticals. This product will be manufactured at Lupin's Aurangabad facility in India.

Powered by Capital Market - Live News

Lupin announced that the Board of Directors of the Company at its meeting held on 14 May 2025, inter alia, have recommended the final dividend of Rs 12 per equity Share (i.e. 600%) , subject to the approval of the shareholders.

Powered by Capital Market - Live News

Securities in F&O Ban:

Central Depository Services (CDSL), Manappuram Finance and Hindustan Copper shares are banned from F&O trading on 15 May 2025.

Upcoming Results:

Abbott India, Allied Blenders and Distillers, Alivus Life Sciences, Arvind, Balrampur Chini Mills, Bombay Burmah Trading Corporation, Bikaji Foods International, BLS International Services, Caplin Point Laboratories, CESC, Cochin Shipyard, Crompton Greaves Consumer Electricals, Godfrey Phillips, JSW Energy, LIC Housing Finance, P N Gadgil Jewellers, Solara Active Pharma, Welspun Enterprises, Allied Blenders and Distillers, Bikaji Foods International, BLS International will declare their result later today.

Stocks to Watch:

Lupin?s consolidated net profit surged 114.9% to Rs 772.52 crore on 13.6% increase in net sales to Rs 5,562.20 crore in Q4 FY25 over Q4 FY24.

Eicher Motors reported a 27.25% increase in consolidated net profit to Rs 1,362.15 crore in Q4 FY25 as against Rs 1,070.45 crore posted in Q4 FY24. Total revenue from operations rose 23.4% YoY to Rs 5,150.38 crore in the quarter ended 31 March 2025.

Tata Power Company?s consolidated net profit jumped 16.49% to Rs 1,042.83 crore on a 7.88% increase in revenue from operations to Rs 17,095.88 crore in Q4 FY25 over Q4 FY24.

Sagility India?s consolidated net profit surged 127.6% to Rs 182.57 crore on a 22.2% jump in net sales to Rs 1,568.48 crore in Q4 FY25 over Q4 FY24.

Tilaknagar Industries reported a 145.9% jump in consolidated net profit to Rs 77.35 crore on 13.1% increase in net sales to Rs 405.81 crore in Q4 FY25 over Q4 FY24.

Baazar Style Retail?s standalone net loss narrowed to Rs 6.39 crore in Q4 FY25 as compared with net loss of Rs 6.43 crore in Q4 FY24. Net sales jumped 54.5% YoY to Rs 345.37 crore in Q4 FY25.

Agi Greenpac reported 49.6% jump in standalone net profit to Rs 96.61 crore on a 13.3% increase in net sales to Rs 704.83 crore in Q4 FY25 over Q4 FY24.

Le Travenues Technology (Ixigo) reported 85.8% jump in consolidated net profit to Rs 16.72 crore on a 72.4% increase in net sales to Rs 281.14 crore in Q4 FY25 over Q4 FY24.

Powered by Capital Market - Live News

Net profit of Lupin rose 114.93% to Rs 772.52 crore in the quarter ended March 2025 as against Rs 359.43 crore during the previous quarter ended March 2024. Sales rose 13.63% to Rs 5562.20 crore in the quarter ended March 2025 as against Rs 4895.11 crore during the previous quarter ended March 2024.

For the full year,net profit rose 71.41% to Rs 3281.62 crore in the year ended March 2025 as against Rs 1914.48 crore during the previous year ended March 2024. Sales rose 12.90% to Rs 22192.11 crore in the year ended March 2025 as against Rs 19656.34 crore during the previous year ended March 2024.

Powered by Capital Market - Live News